This study, called PROMOTE-QI, is looking for better ways to help people stay in treatment for Opioid Use Disorder (OUD). Many people leave treatment early, even though staying on medications like methadone or buprenorphine is linked to better health outcomes. This project will compare different approaches for opioid treatment programs (OTPs) to improve how long patients stay in care. Forty-five BayMark OTPs will be randomly assigned to one of three groups: receiving quality measures and a quality improvement toolkit; receiving these tools plus extra support from a facilitator; or continuing with their usual care. The main goal is to see if these interventions improve the 90-day retention rate for patients in treatment. You can join if you are 18 or older and are a patient at a BayMark OTP. The study status is currently unclear.

Study design

This is a cluster-randomized study involving 45 BayMark Opioid Treatment Programs (OTPs) across multiple states. These OTPs will be divided into three groups, with about 15 sites in each group.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome of 90-day treatment retention is measured at 90 days after treatment initiation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.